*Sponsored by Lifewater Media. Please see disclosures below. |
| "SXTP" Taps Yale for New Cure |
| | | | | Folks, 60 Degrees Pharmaceuticals (SXTP) just unveiled a new patent licensing deal with Yale's schools of medicine and public health. This collaboration aims to further develop tafenoquine, a treatment for babesiosis—a dangerous, tick-borne disease with a high relapse rate in immunocompromised patients. While Lyme disease is more widely recognized, babesiosis carries a much higher fatality risk, prompting urgent demand for new treatment options. The clinical trial, which began enrollment last summer, is now moving forward, with interim data on hospitalized patients expected in September. Anyways... That's all for now! Until Next Time, -Damian | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Sponsored by Lifewater Media. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to penunggangbadai.moneyblog@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for 60 Degrees Pharmaceuticals, Inc. (SXTP) from April 14, 2025 to April 15, 2025. ZipTrader has been compensated six thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for 60 Degrees Pharmaceuticals, Inc. (SXTP) on January 8, 2025. ZipTrader has been compensated fifty thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email, SMS, YouTube, Discord, X/Twitter, and Facebook for 60 Degrees Pharmaceuticals, Inc. (SXTP) from December 9, 2024 to December 12, 2024. ZipTrader may receive additional campaigns in the future by Lifewater Media to distribute media for 60 Degrees Pharmaceuticals, Inc. (SXTP). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in 60 Degrees Pharmaceuticals, Inc. (SXTP). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of 60 Degrees Pharmaceuticals, Inc. (SXTP), increased trading volume, and possibly an increased share price of 60 Degrees Pharmaceuticals, Inc. (SXTP), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
0 Response to ""SXTP" Unleashes Major Pharma Catalyst "
Post a Comment